Arizona Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Arizona Collateral License Agreement is a legally binding document that outlines the terms and conditions of the collaboration between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC). This agreement pertains to the licensing of collateral materials developed during the partnership. Keywords: Arizona Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, collaboration, licensing, collateral materials. The Arizona Collateral License Agreement between Gentling, Inc. and UNT HSC involves the licensing of various collateral materials developed as a result of their collaboration. These collateral materials may include but are not limited to: 1. Research Findings and Publications: This type of collateral material refers to any scientific or research-related findings, breakthroughs, or discoveries made during the partnership. Both parties may have the rights to license, reproduce, and distribute these materials, subject to mutually agreed-upon terms. 2. Intellectual Property: The agreement may also cover the licensing of intellectual property created during the collaboration. This includes patents, copyrights, trademarks, trade secrets, and any other proprietary information. Both Gentling, Inc. and UNT HSC may have the rights to utilize and commercialize these assets, depending on the terms agreed upon. 3. Data and Databases: If the collaboration involves the generation and analysis of large datasets or the development of databases, the Arizona Collateral License Agreement may address the licensing of these valuable resources. It will define the rights and permissions granted to both parties regarding the usage, sharing, and commercialization of the data and databases. 4. Protocols and Methodologies: In cases where novel protocols, methodologies, or experimental techniques are developed during the collaboration, the agreement may cover the licensing of these valuable tools. Both Gentling, Inc. and UNT HSC may hold rights to utilize, modify, and distribute these protocols for further research or commercial purposes. 5. Material Transfer Agreements: If the collaboration involves the exchange of biological or chemical materials between Gentling, Inc. and UNT HSC, the Arizona Collateral License Agreement might include the licensing terms for such materials. These agreements will determine the rights and restrictions on the use, modification, and sharing of the materials provided. It is important to note that the specific types of collateral license agreements may vary depending on the nature of the collaboration and the goals of Gentling, Inc. and UNT HSC. Each agreement will be custom-tailored to address the intellectual property and collateral materials unique to the partnership.

The Arizona Collateral License Agreement is a legally binding document that outlines the terms and conditions of the collaboration between Gentling, Inc. and The University of North Texas Health Science Center (UNT HSC). This agreement pertains to the licensing of collateral materials developed during the partnership. Keywords: Arizona Collateral License Agreement, Gentling, Inc., University of North Texas Health Science Center, collaboration, licensing, collateral materials. The Arizona Collateral License Agreement between Gentling, Inc. and UNT HSC involves the licensing of various collateral materials developed as a result of their collaboration. These collateral materials may include but are not limited to: 1. Research Findings and Publications: This type of collateral material refers to any scientific or research-related findings, breakthroughs, or discoveries made during the partnership. Both parties may have the rights to license, reproduce, and distribute these materials, subject to mutually agreed-upon terms. 2. Intellectual Property: The agreement may also cover the licensing of intellectual property created during the collaboration. This includes patents, copyrights, trademarks, trade secrets, and any other proprietary information. Both Gentling, Inc. and UNT HSC may have the rights to utilize and commercialize these assets, depending on the terms agreed upon. 3. Data and Databases: If the collaboration involves the generation and analysis of large datasets or the development of databases, the Arizona Collateral License Agreement may address the licensing of these valuable resources. It will define the rights and permissions granted to both parties regarding the usage, sharing, and commercialization of the data and databases. 4. Protocols and Methodologies: In cases where novel protocols, methodologies, or experimental techniques are developed during the collaboration, the agreement may cover the licensing of these valuable tools. Both Gentling, Inc. and UNT HSC may hold rights to utilize, modify, and distribute these protocols for further research or commercial purposes. 5. Material Transfer Agreements: If the collaboration involves the exchange of biological or chemical materials between Gentling, Inc. and UNT HSC, the Arizona Collateral License Agreement might include the licensing terms for such materials. These agreements will determine the rights and restrictions on the use, modification, and sharing of the materials provided. It is important to note that the specific types of collateral license agreements may vary depending on the nature of the collaboration and the goals of Gentling, Inc. and UNT HSC. Each agreement will be custom-tailored to address the intellectual property and collateral materials unique to the partnership.